Your browser doesn't support javascript.
loading
Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice.
Smith, Jill P; Cooper, Timothy K; McGovern, Christopher O; Gilius, Evan L; Zhong, Qing; Liao, Jiangang; Molinolo, Alfredo A; Gutkind, J Silvio; Matters, Gail L.
Affiliation
  • Smith JP; From the *National Institute of Diabetes and Digestive and Kidney Disease, The National Institutes of Health, Bethesda, MD; Departments of †Medicine, ‡Comparative Medicine and Pathology, §Public Health Sciences, and ∥Biochemistry and Molecular Biology, The Pennsylvania State University, College of Medicine, Hershey, PA; and ¶National Institute of Dental and Craniofacial Research, The National Institutes of Health, Bethesda, MD.
Pancreas ; 43(7): 1050-9, 2014 Oct.
Article in En | MEDLINE | ID: mdl-25058882
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas / Pancreatic Neoplasms / Precancerous Conditions / Proglumide / Carcinoma in Situ / Receptor, Cholecystokinin A / Receptor, Cholecystokinin B Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Humans Language: En Journal: Pancreas Journal subject: GASTROENTEROLOGIA Year: 2014 Document type: Article Affiliation country: Moldova Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas / Pancreatic Neoplasms / Precancerous Conditions / Proglumide / Carcinoma in Situ / Receptor, Cholecystokinin A / Receptor, Cholecystokinin B Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Humans Language: En Journal: Pancreas Journal subject: GASTROENTEROLOGIA Year: 2014 Document type: Article Affiliation country: Moldova Country of publication: United States